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Abstract
Age is the greatest risk factor for chronic disease and is associated with a
marked decline in functional capacity and quality of life. A key factor con-
tributing to loss of function in older adults is the decline in skeletal muscle
function. While the exact mechanism(s) remains incompletely understood,
age-related mitochondrial dysfunction is thought to play a major role. To
explore this question further, we studied 15 independently living seniors (age:
72  5 years; m/f: 4/11; BMI: 27.6  5.9) and 17 young volunteers (age:
25  4 years; m/f: 8/9; BMI: 24.0  3.3). Skeletal muscle oxidative function
was measured in forearm muscle from the recovery kinetics of muscle oxygen
consumption using near-infrared spectroscopy (NIRS). Muscle oxygen con-
sumption was calculated as the slope of change in hemoglobin saturation dur-
ing a series of rapid, supra-systolic arterial cuff occlusions following a brief
bout of exercise. Aging was associated with a significant prolongation of the
time constant of oxidative recovery following exercise (51.8  5.4 sec vs.
37.1  2.1 sec, P = 0.04, old vs. young, respectively). This finding suggests an
overall reduction in mitochondrial function with age in nonlocomotor skeletal
muscle. That these data were obtained using NIRS holds great promise in
gerontology for quantitative assessment of skeletal muscle oxidative function
at the bed side or clinic.
Introduction
Age is the greatest risk factor for chronic disease, and is
associated with a marked decline in functional capacity
and quality of life (Niccoli and Partridge 2012; Torre
et al. 2015; Jakovljevic 2017). A key factor contributing to
loss of function in aging is the decline in skeletal muscle
function (Buskirk and Hodgson 1987; McCarter 1990;
Brooks and Faulkner 1994). While the exact mechanism
(s) remains incompletely understood, age-related mito-
chondrial dysfunction is thought to play a major role
(Coggan et al. 1993; McCully et al. 1993; Papa 1996; Ker-
ner et al. 2001; Chabi et al. 2008; Marzetti et al. 2008;
Gouspillou et al. 2014; Hepple 2014).
Until recently, the assessment of mitochondrial func-
tion has been limited to invasive muscle biopsies and/or
expensive and time consuming magnetic resonance spec-
troscopy (MRS) techniques, which limit patient access.
Functional evaluation of skeletal muscle oxidative meta-
bolism has also been assessed by pulmonary oxygen
uptake (Grassi et al. 1996; Rossiter et al. 1999); however,
this assessment is indirect, and technically challenging.
Recent advancements in near-infrared spectroscopy (NIRS),
however, have provided a robust, clinical platform to
noninvasively assess muscle oxygen consumption/oxida-
tive function across a wide range of muscles and disease
states (McCully et al. 2011; Brizendine et al. 2013; Erick-
son et al. 2013; Ryan et al. 2013a,b,c, 2014a,b; South-
ern et al. 2014, 2015; Adami and Rossiter 2017). For a
detailed review, readers are directed to (Grassi and
Quaresima 2016; Willingham and McCully 2017). This
novel approach utilizes a series of rapid, supra-systolic
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arterial cuff occlusions to measure postexercise muscle
oxygen consumption recovery kinetics (i.e., mitochondrial
function), which is analogous to the recovery of phospho-
creatine using 31P-MRS (Ryan et al. 2013c). Whether this
approach can be used to assess age-related mitochondrial
dysfunction remains untested. Addressing this fundamen-
tal question is critical to advance current clinical assess-
ment practices and/or the design of large clinical trials
focused on age-related diseases.
The purpose of this study was therefore to compare
skeletal muscle oxidative function between two distinct
age groups (<35 vs. >65 years) using the aforementioned
NIRS approach. We hypothesized that aging would pro-
long postexercise muscle oxygen consumption recovery
kinetics (i.e., mitochondrial function) compared to young




A total of 39 participants between the ages of 20 and
80 years of age were recruited from the local Dallas-Fort
Worth community. The participants were divided into
two groups based on age: young (18–30 years) and elderly
(60–85 years). None of the young participants had any
history of cardiovascular, metabolic, or neurological dis-
ease. Some of the aging individuals had history of hyper-
tension (n = 12) and hypercholesterolemia (n = 10);
however, none had overt heart, metabolic, or neurological
disease, or were current smokers. All subjects presented to
the lab in a fasted state, having abstained from alcohol,
caffeine, and vigorous exercise for at least 24 h. All sub-
jects provided written informed consent before being
enrolled to participate in this study. The study was
approved by the Institutional Review Board at the
University of Texas at Arlington, and conformed to the
standards set by the latest version of the Declaration of
Helsinki.
Activity level was self-reported. Subjects were asked if
they performed regular exercise, as well as frequency,
duration, and type. Activity level was then quantified by
multiplying the frequency by duration and reported as
minutes per week. The intensity of exercise was rated as
follows: walking was defined as mild-to-moderate,
whereas cycling or running was defined as moderate-
to-vigorous.
Experimental protocol
Postexercise muscle oxygen consumption (mVO2) was
assessed as previously described (Ryan et al. 2013c, 2014a,
b). Briefly, each subject was positioned in the supine
position with their nondominant hand extended to com-
fortably reach a handgrip dynamometer (Stoelting 56380;
Stoelting Co., Wheat Lane, IL). A noninvasive dual-wave-
length NIRS optode (OxiPlex TS, Model 95205; ISS,
Champaign, IL) was placed longitudinally over the muscle
belly of the flexor digitorum profundus, the main muscle
responsible for handgrip exercise. This nonlocomotor
muscle was chosen to avoid influence of lower limb activ-
ity discrepancies likely found in these two populations
(i.e., young vs. elderly). Oxyhemoglobin and deoxyhe-
moglobin concentration was measured using a single
channel consisting of eight laser diodes emitting at wave-
lengths of 690 and 830 nm (four at each wavelength).
The laser diodes and photomultiplier were contained in a
light plastic probe consisting of two parallel rows of emit-
ter fibers and one detector fiber bundle comprising
source-detector separations of 2.0, 2.5, 3.0, and 3.5 cm
for both wavelengths. The frequency modulation of laser
intensity was 100 MHz. The NIRS optode was placed
firmly against the skin, held in place with a Velcro strap,
and then encased in a black cloth to block the entry of
light near the optical sensor. A blood pressure cuff
(Hokanson SC5, D. E. Hokanson Inc, Bellevue, WA) was
placed on the upper arm of the exercising hand; the cuff
was powered by a rapid cuff inflator (Hokanson E20).
As illustrated in Figure 1, following a brief baseline
period, a 5 min arterial cuff occlusion was applied in
order to establish each subject’s desaturation reserve.
After stabilization of oxygenated and deoxygenated hemo-
globin, participants were instructed to perform a brief
bout of isometric handgrip exercise (at 50% of each indi-
vidual’s maximal voluntary contraction, or MVC) until
muscle oxygen saturation dropped by ~50% (~10–30 sec).
After exercise cessation, the following series of rapid cuff
inflations were employed in order to form an mVO2
recovery curve: 5 sec on/5 sec off for inflations #1–6,
7 sec on/7 sec off for inflations #7–10, 10 sec on/15 sec
off for inflations #11–14, and 10 sec on/20 sec off for
inflations #15–18. Once oxygenated and deoxygenated
hemoglobin levels returned to baseline levels (typically
between 2 and 5 min), the protocol was repeated and the
average of at least two tests was reported.
Calculation of mVO2 and its recovery rate
The calculation of mVO2 was expressed by the slope of change
in the Hbsat signal (oxygenated hemoglobin + myoglobin
[O2Hb]/(oxygenated hemoglobin + myoglobin [O2Hb] +
deoxygenated hemoglobin + myoglobin [HHb]) 9 100).
The postexercise recovery measurements of mVO2 were fit
to the following monoexponential curve, as previously
described (Ryan et al. 2013c, 2014a,b) using commercially
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available software (OriginPro, OriginLab, Corp., Northamp-
ton, MA):
y ¼ End D ekt ;
where “y” is the relative mVO2 during cuff inflation,
“End” represents the mVO2 value immediately following
the cessation of exercise; delta (“D”) signifies the change
in mVO2 from rest to the end of exercise; “k” is the fit-
ting rate constant; “t” is time. The initial rate of oxygen
consumption was defined as the first measurement imme-
diately after exercise cessation.
Statistical analyses
Statistical analysis was performed using SigmaPlot 13.0
(Systat Software, Inc. San Jose, CA). Data are expressed as
a mean  standard error unless otherwise specified. Nor-
mally distributed data were compared using a Student’s
t-test. If data were not normally distributed, a Mann–
Whitney Rank Sum Test was used to compare group dif-
ferences. Statistical analysis was not performed on activity
level given the gross differences in sample size for the
three predetermined exercise intensities.
Results
Of the 39 participants recruited, data analysis was possible
in all but seven of the subjects. Data from five elderly
participants and two young participants were excluded
due to technical limitations (n = 3) or poor NIRS data
quality (n = 4). Individual characteristics for the 32 who
successfully completed the study are shown in Table 1.
There were no adverse events or contraindications to test-
ing.
A typical NIRS recovery kinetics test is illustrated in
Figure 1. Consistent with our hypothesis, the postexercise
muscle oxygen consumption recovery kinetics — analo-
gous to the recovery of phosphocreatine using 31P-MRS
(Ryan et al. 2013c) — were significantly prolonged in the
elderly participants compared to younger individuals
(51.8  5.4 sec vs. 37.1  2.1 sec, P = 0.04; Fig. 2). The
average r2 value of the fit monoexponential equation was
0.95, with values ranging from 0.91 to 0.99.
Discussion
To the best of our knowledge, this is the first study to
directly assess the effects of age on mitochondrial func-
tion using the rate constant for the recovery of mVO2
measured with NIRS. The major novel finding of this
study was that even in nonlocomotor skeletal muscle, age
significantly prolonged postexercise muscle oxygen con-
sumption recovery kinetics. This data highlights an
age-related decline in muscle oxidative function and
establishes the proof-of-concept for a new noninvasive,
low-cost methodology for future clinical application in
gerontology.
Figure 1. Representative data tracing from an individual subject showing a typical muscle oxygenation test. Oxygenated and deoxygenated
hemoglobin were measured by near-infrared spectroscopy over the flexor digitorum profundus. Data are reported as oxyhemoglobin saturation
(i.e., Hbsat). Each test began with a brief baseline period, followed by a 5 min cuff occlusion in order to establish the desaturation reserve.
Subjects then performed a brief bout of isometric handgrip exercise at 50% of maximal voluntary contraction, followed by a series of rapid
cuff occlusions. The slope of each postexercise cuff occlusion was then measured, plotted against time, and fit to a monoexponential
equation to calculate the muscle oxygen consumption recovery kinetics (as shown in the data insert).
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Only one other study utilizing this specific NIRS
approach has measured muscle oxidative function in
elderly subjects (Southern et al. 2015); however, this study
did not directly assess age-related differences in muscle
oxidative capacity (i.e., data were not compared to young
control group). Instead, the elderly subjects studied in
this prior investigation served as a healthy control group
for a group of patients with heart failure with reduced
ejection fraction. Moreover, the elderly participants
included in this prior investigation were ~10 years
younger than our elderly cohort. Despite modest differ-
ences in the type of forearm exercise performed and near-
infrared technology used, combining these two data sets
portrays a progressive age-related impairment in muscle
oxidative function. Of note, our elderly participants
appear closer to heart failure patients than young healthy
controls or elderly participants ~10 years younger
(Table 2).
That age was associated with a marked reduction in
muscle oxidative function is consistent with previous
studies using more established techniques (Coggan et al.
1993; McCully et al. 1993; Rooyackers et al. 1996; Conley
et al. 2000; Short et al. 2005). For example, Conley et al.
(2000) found aging to impair muscle oxidative function
by ~50% compared to young subjects, which they attribu-
ted to both a decrease in mitochondrial volume and a
Table 1. Subject characteristics.
Young Old P-value
n 17 15 –
Male/female 8/9 4/11 –
Age (years) 25  4 72  5 <0.001
Height (cm) 167.4  12.3 168.1  9.9 0.85
Weight (kg) 69.5  16.0 77.7  15.3 0.126
BMI 24.5  3.3 27.6  6.0 0.05
MVC (kg) 35.1  13.0 26.0  8.4 <0.001
Activity level
Sedentary, min/week (n) – (1) – (0) –
Mild to moderate, min/week (n) 120  79 (3) 182  39 (11) –
Moderate to vigorous, min/week (n) 225  217 (13) 336  289 (4) –
Medications
b-blocker (n) – 1 –
ACE-inhibitor (n) – 2 –
ARB (n) – 3 –
Thyroid hormone (n) – 3 –
Statin (n) – 3 –
NSAIDs/blood thinners (n) – 5 –
Immunosuppressant (n) – 1 –
a₂ agonist (n) – 1 –


























Figure 2. (A) Average postexercise muscle oxygen consumption recovery data for young and elderly participants. Note the slower rate of
recovery in the elderly compared to the young, summarized in panel (B).
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lower oxidative function of the mitochondria. Unlike this
prior investigation, however, the current data were
obtained without the need for invasive muscle biopsies or
expensive and time-consuming MRS techniques. Like
Conley et al. (2000), we interpret the slower recovery rate
of mVO2 in our elderly participants to reflect an overall
reduction in oxidative function.
The exact mechanism responsible for the observed age-
related decline in skeletal muscle oxidative function is
beyond the scope of the present investigation, but is likely
multifactorial. Aging has indeed been associated with a
marked reduction in mitochondrial-specific oxidative
enzymes (Cooper et al. 1992; Boffoli et al. 1994; Rooyack-
ers et al. 1996), mitochondrial DNA mutations (Cooper
et al. 1992; Boffoli et al. 1994; Michikawa et al. 1999),
oxidative damage by reactive oxygen species (Papa 1996),
reduced synthesis of mitochondrial proteins (Rooyackers
et al. 1996), and increased ATP and/or oxidative cost
during exercise (Ferri et al. 2007; Layec et al. 2014).
However, several studies have challenged the concept that
aging itself affects muscle bioenergetics (Kutsuzawa et al.
2001; Carlson et al. 2008; Tevald et al. 2014), and instead
suggest that muscle oxidative function is far more depen-
dent on the muscle group studied (Kent-Braun and Ng
2000; Lanza et al. 2005, 2007; Larsen et al. 2012) (loco-
motor vs. nonlocomotor) and/or the physical activity
level of the individual (Brierley et al. 1996; Rasmussen
et al. 2003; Rimbert et al. 2004; Larsen et al. 2012). That
we specifically studied nonlocomotor muscle argues in
favor of age-specific changes in mitochondrial/oxidative
function, but cannot completely rule this possibility out.
Likewise, our results contradict that of Kutsuzawa et al.
(2001), who failed to find age-related differences in fore-
arm phosphocreatine recovery kinetics using MRS. The
elderly subjects studied herein however, were more than
10 years older (on average), with some history of cardio-
vascular risk factors. We therefore cannot rule out the
possibility that age-related declines in skeletal muscle
oxidative function may not simply be a continuous vari-
able, and is likely influenced by a variety of factors (abso-
lute age, cardiovascular risk, and activity level). Regardless
of mechanism, however, this study highlights the simplic-
ity, robustness, and clinical utility of this novel,
noninvasive spectroscopic approach, and demonstrates its
usefulness in gerontology.
While NIRS does not directly measure skeletal muscle
oxidative function, it has previously been validated
against both in situ muscle biopsy measurements (Ryan
et al. 2014a) and in vivo MRS (Ryan et al. 2013c) with
excellent agreement. We did encounter several instances
where this NIRS-based approach was not successful.
While half of these instances were attributed to nonbio-
logical technical difficulties (i.e., patient compliance and
instrument error), at least two instances appeared to be
related to limb adiposity, which is known to affect
NIRS (Ferrari et al. 2004). This will need to be
accounted for if this technology is going to be incorpo-
rated into large clinical trials. Indeed, advancements in
NIRS penetration depth, such as those previously
described (Koga et al. 2015), may need to be consid-
ered. We also acknowledge that while our findings do
not appear to be explained by the absence or presence
of cardiovascular factors (i.e., hypertension or hyperc-
holesterolemia) or specific medications used, we are in
no way powered to fully test this relationship. More-
over, given the age and medical history of our elderly
group, it is entirely possible that arterial stiffness may
have influenced our results. Indeed, arterial stiffness can
impact tissue hemoglobin oxygenation and therefore
skeletal muscle oxidative recovery kinetics (Dipla et al.
2017). Because arterial stiffness was not measured in
the present study, we cannot rule it out as a potential
contributing factor.
In conclusion, we found that age was associated with a
reduction in skeletal muscle oxidative function using a
novel noninvasive and cost-effective spectroscopic
approach. Taken together, we believe this NIRS-based
approach holds great promise in gerontology (and clinical
medicine in general) as a quantitative tool to assess skele-
tal muscle oxidative function at the bed side, in the clinic,
and for the evaluation of therapeutic efficacy.
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